"almost certainly doing another trial"
this depends on fda agreeing with potency assays. which they have said appear resonable for gvhd and msb are referencing that application for covid. appears reasonable isn't very definitive so i don't think "the next big (covid) announcement" will come until after the fda accepts the gvhd resubmission.
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-126
-
- There are more pages in this discussion • 780 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.0¢ | $1.592M | 1.644M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 43885 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 69249 | 21 |
View Market Depth
| Last trade - 13.03pm 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |